The Post-Bariatric Hypoglycemia market growth is driven by factors like increase in the prevalence of Post-Bariatric ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as GLP-1 receptor agonists, including the popular name brands Ozempic, Wegovy, ...

The studies found no evidence that glucagon causes birth irregularities, pregnancy loss, or other issues related to pregnancy. Baqsimi is approved to treat severely low blood sugar (hypoglycemia ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

Optimised final draft guidance published today recommends 12 SQ-HDM SLIT, also known as Acarizax and made by ALK-Abello, as an option for treating persistent moderate to severe house dust mite ...

While this primarily results in severe hyperglycemia (elevated blood sugar), it may also lead to hypoglycemia in extremely rare cases if the autoantibodies signal excessive glucose reabsorption by ...

Key steps in this homeostatic response are the suppression of endogenous insulin secretion and a stimulus to the secretion of the counterregulatory hormones, glucagon and epinephrine, which act ...

SINGAPORE – The deadly consequences of hoarding were highlighted after a fire in a Hougang flat killed three people on Jan 9. Neighbours had said the family living in the unit were hoarders.

have formed a multi-year strategic partnership to reinforce the importance of prescribing glucagon for all individuals with diabetes who are treated with insulin and/or insulin secretagogues or those ...

The FDA approved Gvoke, a ready-to-use glucagon product, for the treatment of severe hypoglycemia in 2019. The format is potentially more convenient than traditional glucagon kits from the likes ...

The two organizations will work together on a campaign to raise awareness about the importance of glucagon. According to the ADA, nearly half of all people with type 1 diabetes suffer from at least ...

Objective Although intensive glycemic control achieved with insulin therapy increases the incidence of both moderate and severe hypoglycemia, clinical reports of cognitive impairment due to severe ...